These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Ezetimibe: effective and safe treatment for dyslipidaemia associated with nonalcoholic fatty liver disease. Response to: Toth PP, Davidson MH: simvastatin and ezetimibe: combination therapy for the management of dyslipidaemia. Expert Opin. Pharmacother. (2005) 6(1):131-139. Ahmed MH; Saad RA; Osman MM Expert Opin Drug Saf; 2006 Jul; 5(4):487-8. PubMed ID: 16774486 [No Abstract] [Full Text] [Related]
5. Drug treats two sources of cholesterol. Nurse Pract; 2005 Mar; 30(3):70. PubMed ID: 15753829 [No Abstract] [Full Text] [Related]
9. Did a flawed study design affect the results of the VYTAL study? McMahon DE Mayo Clin Proc; 2007 Apr; 82(4):521-2; author reply 522. PubMed ID: 17418081 [No Abstract] [Full Text] [Related]
10. [Drug of the month. Ezetimibe/simvastatin tablet (Inegy)]. Scheen AJ; Radermecker RP Rev Med Liege; 2007 Sep; 62(9):585-90. PubMed ID: 17966796 [TBL] [Abstract][Full Text] [Related]
11. Ezetimibe revisited. Med Lett Drugs Ther; 2008 Aug; 50(1293):67-8. PubMed ID: 18719525 [No Abstract] [Full Text] [Related]
12. In brief: Ezetimibe/simvastatin (Vytorin) in chronic kidney disease. Med Lett Drugs Ther; 2012 Jan; 54(1381):4. PubMed ID: 22233589 [No Abstract] [Full Text] [Related]
13. Simvastatin with or without ezetimibe in familial hypercholesterolemia. Steinberg D N Engl J Med; 2008 Jul; 359(5):529; author reply 532. PubMed ID: 18669434 [No Abstract] [Full Text] [Related]
14. Simvastatin with or without ezetimibe in familial hypercholesterolemia. Eichhorn EJ N Engl J Med; 2008 Jul; 359(5):529-30; author reply 532. PubMed ID: 18677795 [No Abstract] [Full Text] [Related]
15. Simvastatin with or without ezetimibe in familial hypercholesterolemia. Connor WE N Engl J Med; 2008 Jul; 359(5):530; author reply 532-3. PubMed ID: 18677797 [No Abstract] [Full Text] [Related]